제 목    oSFZDhjzWGfwEYG 이 름    Dalton 날 짜    2018/06/28 조 회    1 I'm in a band does pfizer sell generic drugs "There are still millions of people around the globe who have poorly controlled LDL-C," said George Yancopoulos, chief scientific officer at Regeneron. "Three years ago, our Phase I trials generated the first clinical evidence that blocking PCSK9 could markedly lower cholesterol levels in humans. Today, it is very gratifying to be able to report the first Phase III data for this promising potential new class of lipid-lowering agents. It is important to point out that these are just the first of a large amount of data yet to come from our extensive ODYSSEY Phase III program."